---
title: "Kits Eyecare Expands Pangolin Smart Glasses Lineup and Launches New App"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274269527.md"
datetime: "2026-01-30T08:00:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274269527.md)
  - [en](https://longbridge.com/en/news/274269527.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274269527.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274269527.md) | [繁體中文](https://longbridge.com/zh-HK/news/274269527.md)


# Kits Eyecare Expands Pangolin Smart Glasses Lineup and Launches New App

Kits Eyecare Ltd. has announced a major expansion of its Pangolin Smart Glasses franchise in 2026, introducing three new Pangolin 3 designs, including sport and cycling models, and unveiling the upcoming Pangolin 4 platform with expanded functionality. The new smart glasses are designed to operate on an all-new KITS app, soon to launch on the App Store and Google Play. Leveraging its vertically integrated onshore lens lab, KITS will continue to offer prescription lenses paired with smart glasses, delivering orders anywhere in North America in as little as one day. This expansion aims to streamline the customer experience and reinforce KITS’s position as a leader in innovative eyewear technology. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kits Eyecare Ltd. published the original content used to generate this news brief via CNW (Ref. ID: C2689) on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Ocular Therapeutix, Inc. (OCUL.US)](https://longbridge.com/en/quote/OCUL.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [iShares US Medical Devices ETF (IHI.US)](https://longbridge.com/en/quote/IHI.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [SPDR® S&P Health Care Equipment ETF (XHE.US)](https://longbridge.com/en/quote/XHE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [Direxion Daily S&P Biotech Bear 3X ETF (LABD.US)](https://longbridge.com/en/quote/LABD.US.md)

## Related News & Research

- [Perimeter Posts Record 2025 Revenue and Wins FDA Approval for AI Breast Imaging Device](https://longbridge.com/en/news/281274047.md)
- [BUZZ-Tempus AI rises after study shows AI-driven alerts improve heart valve treatment](https://longbridge.com/en/news/281390073.md)
- [Vertex Pharmaceuticals Says US FDA Approves Label Expansion for Alyftrek, Trikafta](https://longbridge.com/en/news/281365753.md)
- [Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update](https://longbridge.com/en/news/281525623.md)
- [Zevenbergen Capital Investments LLC Invests $32.14 Million in Insulet Corporation $PODD](https://longbridge.com/en/news/281179756.md)